相关实验视频
Updated: Jul 9, 2025

07:37
An Adoptive Transfer Model of Rheumatoid Arthritis in Mice
Published on: June 6, 2025
133
HMGCR抑制与类风湿性关节炎的关联:孟德尔的随机化和同地化研究
1Department of Endocrinology and Metabolism, Tianjin Medical University General Hospital, Tianjin, China.
Frontiers in endocrinology
|December 4, 2023
概括
基甲基谷氨基共酶A减少酶 (HMGCR) 的抑制与风湿性关节炎 (RA) 的更高风险有关. 需要进一步研究更安全的HMGCR抑制剂替代物在RA管理中.
科学领域:
- 药物基因组学 药物基因组学
- 类风湿病学 类风湿病学
- 心血管遗传学 心血管遗传学
背景情况:
- 类风湿性关节炎 (RA) 是一种具有复杂病因的慢性自身免疫性疾病.
- 常用于胆固醇管理的基甲基酸辅酶A降解酶 (HMGCR) 抑制剂具有潜在的性作用.
- 了解HMGCR抑制与RA风险之间的关系对于患者安全和治疗优化至关重要.
研究的目的:
- 研究HMGCR抑制与患类风湿性关节炎 (RA) 的风险之间的关联.
- 使用遗传流行病学方法探索潜在的因果关系.
主要方法:
- 使用药物标门德尔随机化 (MR) 分析.
- 进行了遗传局部化分析.
- 使用表达量性特征位点 (eQTL) 和全基因组关联研究 (GWAS) 的HMGCR和低密度脂蛋白胆固醇 (LDL-C) 数据.
主要成果:
- 基因代理的HMGCR表达与RA风险呈负相关性 (OR=0.996).
- HMGCR介导的低密度脂蛋白胆固醇与RA风险 (OR=0.995) 有负相关性.
- 局部化分析表明,HMGCR位置和RA风险因素之间存在共同的因果变异.
结论:
- 抑制HMGCR与风湿性关节炎的风险增加有关.
- 这种关联可能受到当前吸烟和肥胖等因素的影响.
- 对其他RA管理策略的进一步研究是有必要的.
更多相关视频
09:07Prediction and Validation of Gene Regulatory Elements Activated During Retinoic Acid Induced Embryonic Stem Cell Differentiation
Published on: June 21, 2016
8.2K
07:26High-resolution Melting PCR for Complement Receptor 1 Length Polymorphism Genotyping: An Innovative Tool for Alzheimer's Disease Gene Susceptibility Assessment
Published on: July 18, 2017
11.9K
相关概念视频
Genome-wide Association Studies-GWAS
13.5K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
13.5K
The JAK-STAT Signaling Pathway
8.9K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
8.9K